Literature DB >> 10431108

Optimality score for the neurologic examination of the infant at 12 and 18 months of age.

L Haataja1, E Mercuri, R Regev, F Cowan, M Rutherford, V Dubowitz, L Dubowitz.   

Abstract

The aim of this study was to develop and validate a simple, quantifiable, neurologic examination for infants between 2 and 24 months of age. The assessment consists of 37 items, divided into 3 sections. The first section includes 26 items assessing cranial nerve function, posture, movements, tone, and reflexes; the second section of 8 items documents the development of motor function, and the third section of 3 items evaluates the state of behavior. We applied this assessment to a cohort of ninety-two 12-month-old infants and forty-three 18-month-old infants, with no known perinatal risk factors. The proforma presented has been designed according to the frequency distribution of the neurologic findings in this cohort. Each item is scored individually, and a global score is the sum of all individual scores. The quantitative score enhances the value of this examination, both in clinical practice and in research settings.

Entities:  

Mesh:

Year:  1999        PMID: 10431108     DOI: 10.1016/s0022-3476(99)70016-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


  58 in total

1.  T2 relaxation values in the developing preterm brain.

Authors:  Serena J Counsell; Nigel L Kennea; Amy H Herlihy; Joanna M Allsop; Michael C Harrison; Frances M Cowan; Joseph V Hajnal; Bridget Edwards; A David Edwards; Mary A Rutherford
Journal:  AJNR Am J Neuroradiol       Date:  2003-09       Impact factor: 3.825

2.  Predicting motor outcome and death in term hypoxic-ischemic encephalopathy.

Authors:  M Martinez-Biarge; J Diez-Sebastian; O Kapellou; D Gindner; J M Allsop; M A Rutherford; F M Cowan
Journal:  Neurology       Date:  2011-06-14       Impact factor: 9.910

3.  Hammersmith Infant Neurological Examination Asymmetry Score Distinguishes Hemiplegic Cerebral Palsy From Typical Development.

Authors:  Krystal Hay; MaryAnn Nelin; Helen Carey; Olena Chorna; Melissa Moore-Clingenpeel Ma Mas; Nathalie Maitre
Journal:  Pediatr Neurol       Date:  2018-07-25       Impact factor: 3.372

4.  Cost Effectiveness of Nusinersen in the Treatment of Patients with Infantile-Onset and Later-Onset Spinal Muscular Atrophy in Sweden.

Authors:  Santiago Zuluaga-Sanchez; Megan Teynor; Christopher Knight; Robin Thompson; Thomas Lundqvist; Mats Ekelund; Annabelle Forsmark; Adrian D Vickers; Andrew Lloyd
Journal:  Pharmacoeconomics       Date:  2019-06       Impact factor: 4.981

5.  Prognostic value of EEG performed at term age in preterm infants.

Authors:  Teresa Randò; Daniela Ricci; Rita Luciano; M Flavia Frisone; Giovanni Baranello; Tania Tonelli; Marika Pane; Costantino Romagnoli; Giuseppe Tortorolo; Eugenio Mercuri; Francesco Guzzetta
Journal:  Childs Nerv Syst       Date:  2005-06-01       Impact factor: 1.475

6.  Implementation of the Hammersmith Infant Neurological Examination in a High-Risk Infant Follow-Up Program.

Authors:  Nathalie L Maitre; Olena Chorna; Domenico M Romeo; Andrea Guzzetta
Journal:  Pediatr Neurol       Date:  2016-09-21       Impact factor: 3.372

7.  Associations between regional brain volumes at term-equivalent age and development at 2 years of age in preterm children.

Authors:  Annika Lind; Riitta Parkkola; Liisa Lehtonen; Petriina Munck; Jonna Maunu; Helena Lapinleimu; Leena Haataja
Journal:  Pediatr Radiol       Date:  2011-05-02

8.  Neonatal ECMO Study of Temperature (NEST)--a randomised controlled trial.

Authors:  David J Field; Richard Firmin; Denis V Azzopardi; Frances Cowan; Edmund Juszczak; Peter Brocklehurst
Journal:  BMC Pediatr       Date:  2010-04-19       Impact factor: 2.125

9.  Usefulness of an early neurofunctional assessment in predicting neurodevelopmental outcome in very low birthweight infants.

Authors:  O Picciolini; M L Giannì; C Vegni; M Fumagalli; F Mosca
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2006-03       Impact factor: 5.747

10.  The neurological assessment in young children treated with artesunate monotherapy or artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria.

Authors:  Michael T Ambler; Lilly M Dubowitz; Ratree Arunjerdja; Eh Paw Hla; Kyaw Lay Thwai; Jacher Viladpainguen; Pratap Singhasivanon; Christine Luxemburger; François Nosten; Rose McGready
Journal:  Malar J       Date:  2009-09-02       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.